Showing 101 - 120 results of 492 for search '"Hepatitis C"', query time: 0.05s Refine Results
  1. 101
  2. 102

    Capacity Enhancement of Hepatitis C Virus Treatment through Integrated, Community-Based Care by Warren D Hill, Gail Butt, Maria Alvarez, Mel Krajden

    Published 2008-01-01
    “…BACKGROUND: An estimated 250,000 Canadians are infected with the hepatitis C virus (HCV). The present study describes a cohort of individuals with HCV referred to community-based, integrated prevention and care projects developed in British Columbia. …”
    Get full text
    Article
  3. 103

    Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany by Jona T. Stahmeyer, Svenja Schauer, Siegbert Rossol, Hans Heinrich Wedemeyer, Daniel Wirth, Florence Bianic, Christian Krauth

    Published 2013-12-01
    “…**Background:** About 400,000-500,000 people are infected with hepatitis C in Germany. Long-term consequences are the development of liver cirrhosis and hepatocellular carcinoma. …”
    Get full text
    Article
  4. 104

    Viral Response to Specifically Targeted Antiviral Therapy for Hepatitis C and the Implications for Treatment Success by Curtis L Cooper

    Published 2010-01-01
    “…Currently, hepatitis C virus (HCV) antiviral therapy is characterized by long duration, a multitude of side effects, difficult administration and suboptimal success; clearly, alternatives are needed. …”
    Get full text
    Article
  5. 105

    Hepatitis C Virus Evasion from RIG-I-Dependent Hepatic Innate Immunity by Helene Minyi Liu, Michael Gale

    Published 2010-01-01
    “…Exposure to hepatitis C virus (HCV) usually results in persistent infection that often develops into chronic liver disease. …”
    Get full text
    Article
  6. 106

    Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C: Open Issues and Future Perspectives by Hee Bok Chae, Seon Mee Park, Sei Jin Youn

    Published 2013-01-01
    “…Currently, two direct-acting antivirals (DAAs) show well-established efficacy against hepatitis C virus (HCV), namely, first-wave protease inhibitors telaprevir and boceprevir. …”
    Get full text
    Article
  7. 107

    Factors Associated with Spontaneous Clearance of Hepatitis C Virus among Illicit Drug Users by Jason Grebely, Jesse D Raffa, Calvin Lai, Mel Krajden, Brian Conway, Mark W Tyndall

    Published 2007-01-01
    “…BACKGROUND: Spontaneous clearance of hepatitis C virus (HCV) occurs in approximately 25% of individuals.…”
    Get full text
    Article
  8. 108

    Treatment-Resistant Hepatitis C Viral Infection: A Case Report and Literature Review by Victoria Green, Marina Roytman

    Published 2022-01-01
    “…Hepatitis C virus (HCV) is an ongoing global public health threat affecting millions worldwide. …”
    Get full text
    Article
  9. 109

    Hepatitis C as a Prognostic Indicator among Noncirrhotic Patients Hospitalized with Alcoholic Hepatitis by Paul J Thuluvath, Eric Ahn, Geoffrey C Nguyen

    Published 2013-01-01
    “…OBJECTIVE: A nationwide analysis of alcoholic hepatitis (AH) admissions was conducted to determine the impact of hepatitis C virus (HCV) infection on short-term survival and hospital resource utilization.…”
    Get full text
    Article
  10. 110
  11. 111
  12. 112

    Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians by Curtis L Cooper, Robert J Bailey, Vince G Bain, Frank Anderson, Eric M Yoshida, Mel Krajden, Paul Marotta, for the Canadian Pegasys Study Group

    Published 2008-01-01
    “…BACKGROUND: There is little published information on baseline characteristics and therapeutic outcomes in hepatitis C virus (HCV)-infected Aboriginal Canadians. …”
    Get full text
    Article
  13. 113

    Autoimmunity and Extrahepatic Manifestations in Treatment-Naïve Children with Chronic Hepatitis C Virus Infection by Giuseppe Indolfi, Elisa Bartolini, Biagio Olivito, Chiara Azzari, Massimo Resti

    Published 2012-01-01
    “…Hepatitis C virus (HCV) infection has been associated with autoimmunity and extrahepatic manifestations in adults. …”
    Get full text
    Article
  14. 114

    Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy by Sylvia Drazilova, Jakub Gazda, Martin Janicko, Peter Jarcuska

    Published 2018-01-01
    “…Patients with chronic hepatitis C have both higher prevalence of diabetes mellitus type 2 (T2DM) and increased cardiovascular risk compared to never infected people. …”
    Get full text
    Article
  15. 115

    Serum IL-33 Levels Are Associated with Liver Damage in Patients with Chronic Hepatitis C by Juan Wang, Pingwei Zhao, Hui Guo, Xiguang Sun, Zhenyu Jiang, Lijun Xu, Junyan Feng, Junqi Niu, Yanfang Jiang

    Published 2012-01-01
    “…This study examined the potential role of IL-33 in the pathogenic process of chronic hepatitis C (CHC) in Chinese patients. The levels of serum IL-33 and sST2 in 154 patients with CHC, 24 with spontaneously resolved HCV (SR-HCV) infection and 20 healthy controls (HC), were analyzed by ELISA. …”
    Get full text
    Article
  16. 116
  17. 117

    Living with Hepatitis C Virus: A Systematic Review and Narrative Synthesis of Qualitative Literature by Laura E. Dowsett, Stephanie Coward, Diane L. Lorenzetti, Gail MacKean, Fiona Clement

    Published 2017-01-01
    “…The aim of this systematic review was to understand the experiences of living with Hepatitis C Virus (HCV). Methods. Five databases were searched from inception until January 19, 2015. …”
    Get full text
    Article
  18. 118

    Pathogenic Role of Iron Deposition in Reticuloendothelial Cells during the Development of Chronic Hepatitis C by Hironori Mitsuyoshi, Kohichiroh Yasui, Kanji Yamaguchi, Masahito Minami, Takeshi Okanoue, Yoshito Itoh

    Published 2013-01-01
    “…Aim. Chronic hepatitis C (CHepC) is frequently associated with hepatic iron overload, yet mechanisms underlying iron-induced liver injury have not been elucidated. …”
    Get full text
    Article
  19. 119
  20. 120

    Failure of Ketoprofen and Interferon Combination Therapy to Improve Interferon-Resistant Chronic Hepatitis C by Frank H Anderson, Lecheng Zeng, Eric M Yoshida, Natalie R Rock

    Published 1997-01-01
    “…Preliminary reports suggest that patients with interferon (IFN)-resistant chronic hepatitis C respond better to a combination of IFN-α and nonsteroidal anti-inflammatory drugs than to IFN alone. …”
    Get full text
    Article